Form 4: BiomX Inc. Director Alan Charles Moses Acquires Options
SEC Form 4 Filing
Director Alan Charles Moses reports acquisition of options to purchase 176,000 shares of BiomX Inc. common stock.
Summary
- On July 11, 2024, Alan Charles Moses, a director of BiomX Inc., acquired options to purchase 176,000 shares of the company's common stock.
- The exercise price of these options is $0.363 per share.
- The options vest over four years, with 25% vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.
- Following the transaction, Moses directly owns options for 176,000 shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It simply reports a transaction.
Positives
- The acquisition of options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- Shareholders are informed about the change in beneficial ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of the transaction: Alan Charles Moses acquired options to purchase BiomX Inc. common stock. |
| 07/11/2025 | 25% of the options vest. |
| 07/15/2024 | Date of signature for the Form 4 filing. |
| 07/11/2034 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.